Albiñana V - Search Results

1

A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2.

Errasti Díaz S, Peñalva M, Recio-Poveda L, Vilches S, Casado-Vela J, Pérez Pérez J, Botella LM, Albiñana V, Cuesta AM. Errasti Díaz S, et al. Among authors: albinana v. J Clin Med. 2022 May 28;11(11):3053. doi: 10.3390/jcm11113053. J Clin Med. 2022. PMID: 35683441 Free PMC article.

2

Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia.

Fontalba A, Fernandez-L A, García-Alegria E, Albiñana V, Garrido-Martin EM, Blanco FJ, Zarrabeitia R, Perez-Molino A, Bernabeu-Herrero ME, Ojeda ML, Fernandez-Luna JL, Bernabeu C, Botella LM. Fontalba A, et al. Among authors: albinana v. BMC Med Genet. 2008 Aug 1;9:75. doi: 10.1186/1471-2350-9-75. BMC Med Genet. 2008. PMID: 18673552 Free PMC article.

3

Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.

Albiñana V, Bernabeu-Herrero ME, Zarrabeitia R, Bernabéu C, Botella LM. Albiñana V, et al. Thromb Haemost. 2010 Mar;103(3):525-34. doi: 10.1160/TH09-07-0425. Epub 2010 Feb 2. Thromb Haemost. 2010. PMID: 20135064

4

Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.

Albiñana V, Sanz-Rodríguez F, Recio-Poveda L, Bernabéu C, Botella LM. Albiñana V, et al. Mol Pharmacol. 2011 May;79(5):833-43. doi: 10.1124/mol.110.067447. Epub 2011 Feb 10. Mol Pharmacol. 2011. PMID: 21310938

5

Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.

Albiñana V, Recio-Poveda L, Zarrabeitia R, Bernabéu C, Botella LM. Albiñana V, et al. Thromb Haemost. 2012 Jul;108(1):41-53. doi: 10.1160/TH11-11-0809. Epub 2012 May 3. Thromb Haemost. 2012. PMID: 22552254

6

Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1.

Fontalba A, Fernández-Luna JL, Zarrabeitia R, Recio-Poveda L, Albiñana V, Ojeda-Fernández ML, Bernabéu C, Alcaraz LA, Botella LM. Fontalba A, et al. Among authors: albinana v. BMC Med Genet. 2013 Nov 25;14:121. doi: 10.1186/1471-2350-14-121. BMC Med Genet. 2013. PMID: 24267784 Free PMC article.

7

Research on potential biomarkers in hereditary hemorrhagic telangiectasia.

Botella LM, Albiñana V, Ojeda-Fernandez L, Recio-Poveda L, Bernabéu C. Botella LM, et al. Among authors: albinana v. Front Genet. 2015 Mar 31;6:115. doi: 10.3389/fgene.2015.00115. eCollection 2015. Front Genet. 2015. PMID: 25873934 Free PMC article.

8

Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.

Albiñana V, Villar Gómez de Las Heras K, Serrano-Heras G, Segura T, Perona-Moratalla AB, Mota-Pérez M, de Campos JM, Botella LM. Albiñana V, et al. Orphanet J Rare Dis. 2015 Sep 22;10:118. doi: 10.1186/s13023-015-0343-5. Orphanet J Rare Dis. 2015. PMID: 26394686 Free PMC article.

9

Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.

Zarrabeitia R, Ojeda-Fernandez L, Recio L, Bernabéu C, Parra JA, Albiñana V, Botella LM. Zarrabeitia R, et al. Among authors: albinana v. Thromb Haemost. 2016 Jun 2;115(6):1167-77. doi: 10.1160/TH15-03-0239. Epub 2016 Jan 28. Thromb Haemost. 2016. PMID: 26818701

10

Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.

Albiñana V, Zafra MP, Colau J, Zarrabeitia R, Recio-Poveda L, Olavarrieta L, Pérez-Pérez J, Botella LM. Albiñana V, et al. BMC Med Genet. 2017 Feb 23;18(1):20. doi: 10.1186/s12881-017-0380-0. BMC Med Genet. 2017. PMID: 28231770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page